Skip to contentSMITH SANDFORD D — CYTOKINETICS INC insider: 302 transactions · InsiderLensSMITH SANDFORD D
- Director at ARIAD PHARMACEUTICALS INC · on record since Jan 19, 2006
- Director at CYTOKINETICS INC · on record since Mar 7, 2012
- Director at Aegerion Pharmaceuticals, Inc. · on record since Jan 5, 2012
- Director at QLT INC/BC · on record since Dec 27, 2016
- Director at Neuralstem, Inc. · on record since Jul 31, 2014
- Director at NEXMED INC · on record since Aug 12, 2014
- Chief Executive Officer at Aegerion Pharmaceuticals, Inc. · on record since Aug 25, 2015
- Director at AKCEA THERAPEUTICS, INC. · on record since Jul 13, 2017
- Senior Vice President at GENZYME CORP · on record since Jun 6, 2005
Insider trading activity of SMITH SANDFORD D
- Transactions on record
- 302
- since Jan 20, 2004
- Open-market buys
- 2
- $41.6K
- Open-market sells
- 56
- $17.9M
- Companies traded
- 8
- last filing Jan 3, 2024
Figures computed from official regulatory filings — methodology.
Companies where SMITH SANDFORD D has traded
- CYTOKINETICS INC150 tx · $10.2M · Jan 3, 2024
- AKCEA THERAPEUTICS, INC.5 tx · $366.9K · Oct 13, 2020
- Neuralstem, Inc.4 tx · Jul 5, 2018
- NEXMED INC10 tx · $50.9K · Jan 8, 2018
- QLT INC/BC4 tx · Feb 3, 2017
- Aegerion Pharmaceuticals, Inc.30 tx · $1.4M · Nov 30, 2016
- GENZYME CORP78 tx · $40.7M · Apr 6, 2011
- ARIAD PHARMACEUTICALS INC21 tx · $123.7K · Jul 11, 2008
Track record of SMITH SANDFORD D
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of SMITH SANDFORD D
Co-insiders of SMITH SANDFORD D
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
FITZGERALD EDWARD MAKCEA THERAPEUTICS, INC. +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jan 3, 2024 | Award | 148 | 84.12 USD | $12.4K | SEC |
| Oct 3, 2023 | Award | 448 | 27.88 USD | $12.5K | SEC |
| Jul 5, 2023 | Award | 374 | 33.36 USD | $12.5K | SEC |
| May 18, 2023 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| May 18, 2023 | Award | 5,000 | 0.00 USD | $0 | SEC |
| Apr 5, 2023 | Award | 298 | 37.71 USD | $11.2K | SEC |
| Jan 4, 2023 | Award | 253 | 44.35 USD | $11.2K | SEC |
| Oct 5, 2022 | Award | 110 | 51.11 USD | $5.6K | SEC |
| Sep 2, 2022 | Exercise | 5,834 | 24.32 USD | $141.9K | SEC |
| Sep 2, 2022 | Exercise | 3,035 | 10.68 USD | $32.4K | SEC |
| Sep 2, 2022 | Exercise | 2,500 | 37.89 USD | $94.7K | SEC |
| Sep 2, 2022 | ExerciseD | -5,834 | 0.00 USD | $0 | SEC |
| Sep 2, 2022 | ExerciseD | -3,035 | 0.00 USD | $0 | SEC |
| Sep 2, 2022 | ExerciseD | -2,500 | 0.00 USD | $0 | SEC |
| Sep 2, 2022 | Sell | -11,369 | 53.97 USD | $613.6K | SEC |
| Jul 12, 2022 | Award | 137 | 41.00 USD | $5.6K | SEC |
| May 11, 2022 | Award | 5,000 | 0.00 USD | $0 | SEC |
| May 11, 2022 | AwardD | 10,000 | 0.00 USD | $0 | SEC |
| Apr 1, 2022 | Award | 146 | 38.38 USD | $5.6K | SEC |
| Jan 4, 2022 | Award | 122 | 46.00 USD | $5.6K | SEC |
| Dec 28, 2021 | ExerciseD | -4,166 | 0.00 USD | $0 | SEC |
| Dec 28, 2021 | ExerciseD | -20,000 | 0.00 USD | $0 | SEC |
| Dec 28, 2021 | Sell | -4,166 | 45.79 USD | $190.8K | SEC |
| Dec 28, 2021 | Exercise | 20,000 | 21.61 USD | $432.2K | SEC |
| Dec 28, 2021 | Exercise | 4,124 | 15.43 USD | $63.6K | SEC |